| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1476-5381.1976.TB07442.X |
| P953 | full work available at URL | http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1976.tb07442.x/fullpdf |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1476-5381.1976.tb07442.x | ||
| https://europepmc.org/articles/PMC1666877 | ||
| https://europepmc.org/articles/PMC1666877?pdf=render | ||
| P932 | PMC publication ID | 1666877 |
| P698 | PubMed publication ID | 3248 |
| P5875 | ResearchGate publication ID | 23130138 |
| P2093 | author name string | A. R. Green | |
| Grahame-Smith DG | |||
| D. G. Grahame-Smith | |||
| J. P. Evans | |||
| A. F. Tordoff | |||
| P2860 | cites work | Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor | Q39985530 |
| The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine | Q40916433 | ||
| Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan | Q40925721 | ||
| Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain | Q41293306 | ||
| Letter: Effect of chlorimipramine on the rate of tryptophan hydroxylation in the intact and transected spinal cord | Q44175764 | ||
| The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function | Q48476932 | ||
| The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats | Q48510055 | ||
| TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats | Q48514765 | ||
| Effects of electroconvulsive shock on the metabolism of 5-hydroxytryptamine in the rat brain | Q48718552 | ||
| Increase of brain tryptophan by electroconvulsive shock in rats | Q48759240 | ||
| Hydroxytryptamine turnover decreased by the antidepressant drug chlorimipramine | Q48938512 | ||
| In Vivo Measurement of Brain Serotonin Turnover | Q51195506 | ||
| Serotonin Release from Brain Slices by Electrical Stimulation: Regional Differences and Effect of LSD | Q51205824 | ||
| Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS | Q66843225 | ||
| Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission | Q68608468 | ||
| Effects of chlorimipramine and protriptyline on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice | Q69114615 | ||
| The determination of tryptophan in plasma, liver, and urine | Q72203873 | ||
| A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES | Q78560273 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| nervous system | Q9404 | ||
| P304 | page(s) | 193-199 | |
| P577 | publication date | 1976-02-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs | |
| P478 | volume | 56 |
| Q41739738 | 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice |
| Q49106889 | ?-Adrenergic receptor binding in different regions of rat brain after various intensities of electroshock: Relationship to postictal EEG |
| Q42638498 | A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena |
| Q41531201 | A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions |
| Q48164365 | Alterations in GABA metabolism and Met-enkephalin content in rat brain following repeated electroconvulsive shocks |
| Q38151087 | Antidepressants and serotonergic neurotransmission: an integrative review |
| Q48739249 | Augmentation of rat brain endogenous monoamine oxidase inhibitory activity (tribulin) by electroconvulsive shock |
| Q71193915 | Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour |
| Q39501568 | Changes in gamma-aminobutyric acid biochemistry and seizure threshold |
| Q49125373 | Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT. |
| Q42567623 | Changes in the behavioural response to a TRH analogue following chronic amitriptyline treatment and repeated electroconvulsive shock in the rat. |
| Q74126285 | Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study |
| Q73593299 | Chronic electroconvulsive shock decreases (+/-) 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane hydrochloride (DOI)-induced wet-dog shake behaviors of dexamethasone-treated rats |
| Q48856290 | Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches |
| Q41543073 | Comparison of regional brain 5-HT and 5-HIAA content in flexor and extensor rats |
| Q43745072 | Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment |
| Q40139757 | Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments |
| Q72378745 | Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment |
| Q40079616 | Drugs: Guide and caveats to explanatory and descriptive approaches—I. A critical evaluation of the current status of antidepressant drugs |
| Q44967639 | Early changes in rat brain 5-hydroxytryptamine synthesis after a single electroconvulsive shock |
| Q48830901 | Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour |
| Q46203748 | Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder |
| Q72623301 | Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain—I metabolic studies |
| Q41141018 | Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens |
| Q40747144 | Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine |
| Q39501592 | Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat brain |
| Q70508291 | Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat |
| Q59010104 | Electroconvulsive Shock: Effect on Pineal and Hypothalamic Indoles |
| Q70795365 | Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat |
| Q67329851 | Electroconvulsive therapy |
| Q64813443 | Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon |
| Q70490989 | Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain |
| Q68695542 | Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice |
| Q39662597 | Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy |
| Q39710466 | Environmental, Toxicological, and Related Aspects of Tryptophan Metabolism with Particular Reference to the Central Nervous System |
| Q40086791 | Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine |
| Q42111276 | Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats |
| Q48875772 | Increased permeability of blood brain barrier after electro-convulsive shocks (ECS). |
| Q51874182 | Lack of effect of repeated electroconvulsive shock on [3H]spiroperidol and [2H]5-hydroxytryptamine binding and cholinergic parameters in rat brain. |
| Q46533443 | MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt. |
| Q39472392 | Mechanism of the antidepressant action of electroconvulsive therapy |
| Q39501585 | Neurochemical mechanisms of mood stabilization. Focus on electroconvulsive therapy |
| Q48249072 | Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment |
| Q36096163 | On the mechanism of action of electroconvulsive therapy: some behavioural and biochemical consequences of repeated electrically induced seizures in rats [proceedings] |
| Q46094167 | Platelet serotonin transport after a single ECT. |
| Q64786855 | Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms |
| Q48412274 | Reactivity of the dopa-dopamine-noradrenaline-adrenaline system in epileptic patients |
| Q67296295 | Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock |
| Q40047013 | Relaxant effects of dopamine and isoprenaline on canine isolated coronary arteries--relationship to cyclic AMP production [proceedings] |
| Q40049586 | Relevance of the enhanced 5-hydroxytryptamine behavioural responses in rats to electroconvulsive therapy [proceedings] |
| Q68082551 | Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats |
| Q48165398 | Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes |
| Q40212690 | Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbens |
| Q73862998 | Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus |
| Q40050309 | Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses |
| Q40146645 | Serotonin receptor changes after chronic antidepressant treatments: Ligand binding, electrophysiological, and behavioral studies |
| Q41736922 | Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy |
| Q72720782 | Some effects of chronic antidepressant treatments on rat brain monoaminergic systems |
| Q60054603 | Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters |
| Q66704345 | The Neuropharmacology of Depression |
| Q71530599 | The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rat |
| Q48620311 | The effect of repeated electroconvulsive shock on the function of THIP, a GABA agonist |
| Q51864074 | The effect of repeated electroconvulsive shocks on growth hormone secretion and growth hormone responses to clonidine in the intact rat. |
| Q39310375 | The effects of drugs on the processes regulating the functional activity of brain monoamines |
| Q39271303 | The scientific status of electro-convulsive therapy |
| Q43546334 | Transcranial magnetic stimulation in an amphetamine hyperactivity model of mania |
| Q67040026 | Treatment of depression |
| Q39932207 | beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses |
Search more.